The following is from The Vaccine Reaction. The US Food and Drug Administration (FDA) has notified six influenza vaccine manufacturers that they must add a warning about the risk of febrile (fever-related) seizures to their product labels. According to The […]
FDA requires flu shot makers to add febrile seizure warning Read More »
The following is from Children’s Health Defense. Nirsevimab, marketed by Sanofi and AstraZeneca as Beyfortus is a drug developed to protect infants from RSV (respiratory syncytial virus), a virus that can lead to serious respiratory infections. It was fast-tracked for approval by the US
(READ) FDA fast-tracked RSV shot linked to infant deaths Read More »
Today, most countries have officially determined that most kids don’t need COVID shots. But in the U.S., the CDC still recommends COVID vaccinations for babies and children six months and older. I found that American doctors are sometimes given a
The following is from The Vaccine Reaction. Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines, has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States
Pfizer settles Zantac cancer lawsuits for $250 million Read More »
The following is from Reuters. Drugmakers including Pfizer (PFE.N), Sanofi (SASY.PA) and Takeda Pharmaceutical (4502.T) plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. Excluding different doses
Drugmakers set to raise prices on 500+ drugs this month Read More »
A Trump-era rule sought to impose a “most favored nation” status on the prescription drug industry. It mandated that drug companies could not charge American citizens more than what’s charged in other countries for the same medicine. Currently, Americans “subsidize”
Drugmakers to raise prices on at least 350 drugs this month Read More »
The federal government has advised pharmaceutical companies AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi, and United Therapeutics that they are in violation of a federal drug-pricing program. The program, called “340B,” was created in 1992. It requires drug makers to
Feds: Pharmaceutical companies overcharged for medicine during pandemic Read More »
